Abstract:BACKGROUND & OBJECTIVE:Protein kinase CK2 is an evolutionarily conserved serine/threonine kinase that is upregulated and can serve as an oncogene in many cancer cells. Targeted inhibition of CK2 could be useful in the treatment of many cancers. To search specific CK2 inhibitors we investigated the direct effect of tyrphostin AG1109 on recombinant human protein kinase CK2 holoenzyme and its kinetics.METHODS:Recombinant human protein kinase CK2 alpha and beta subunits were cloned and expressed by gene engineering, and purified to homogeneous. The two subunits were mixed at the same molar ratio and reconstituted CK2 holoenzyme, which exerted the maximum biological activity. The CK2 activity was assayed by detecting incorporation of 32P of [gamma-32P]ATP or [gamma-32P]GTP into the substrate in various conditions.RESULTS:The recombinant human CK2 was the second messengers (Ca2+, cAMP, and cGMP) independent protein kinase, the characterization and function of the reconstituted holoenzyme were consistent with those of native CK2. AG1109 strongly inhibited the holoenzyme activity of recombinant human protein kinase CK2 with an IC50 of 9.7 mumol/L, which was slightly more effective than 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) and N-(2-aminoethyl)-5-chloronaphthalene-1-sulfonamide (A3), which were both known CK2 special inhibitors. Kinetic studies of AG1109 on recombinant human CK2 showed that the inhibition was mixed (competitive is dominant) with GTP and noncompetitive with casein.CONCLUSIONS:AG1109 is an effective inhibitor of recombinant human protein kinase CK2 holoenzyme. The recombinant human protein kinase CK2 might be used as a molecular target for simpler screening and development of more effective inhibitors of CK2.

[Inhibitory Effect and Its Kinetic Analysis of Baicalein on Recombinant Human Protein Kinase CK2 Holoenzyme].

Inhibitory Effect of Kaempferol on Protein Kinase CK2 in vitro and in HL-60 Cells

Study on Selectivity of Inhibitor BD2 for PKA over PKC beta II

[Inhibitory Effect of AG1109 on Recombinant Human Protein Kinase CK2 Holoenzyme].

Inhibitory effect of luteolin on recom- binant human protein kinase CK2 holoenzyme in vitro

[Inhibitory Effect and Kinetic Analysis of Sodium Quercetin-7,4'-disulphate on Recombinant Human Protein Kinase CK2 Holoenzyme].

Inhibitory Effect and Its Kinetic Analysis of Tyrphostin AG1478 on Recombinant Human Protein Kinase CK2 Holoenzyme.

Inhibitory Effect and Kinetic Analysis of 1,8-Dihydroxyanthraquinone on Recombinant Human Protein Kinase CK2 Holoenzyme

Prokaryotic Expression, Purification and Characterization of Recombinant Human Protein Kinase CK2β Subunit

The Study Of Digitoflavone For The Inhibition Of Protein Kinase Ck2 In Hl-60 Cells

Baicalein Triggers Autophagy and Inhibits the Protein Kinase B/Mammalian Target of Rapamycin Pathway in Hepatocellular Carcinoma HepG2 Cells.

Baicalein inhibits inflammatory and catabolic gene expression in interleukin-1 beta-induced human chondrocytes

Baicalein Selectively Induce Apoptosis in Human Leukemia K562 Cells

Baicalein Inhibits The Invasion And Metastatic Capabilities Of Hepatocellular Carcinoma Cells Via Down-Regulation Of The Erk Pathway

Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2.

Baicalein Inhibits MMPs Expression via a MAPK-Dependent Mechanism in Chondrocytes.

Discovery of Potent, Orally Active Compounds of Tyrosine Kinase and Serine/Threonine-Protein Kinase Inhibitor with Anti-Tumor Activity in Preclinical Assays

Structure-activity Relationship of 7 Flavonoids on Recombinant Human Protein Kinase CK2 Holoenzyme

Baicalein Inhibits The Invasion, Migration And Epithelial-Mesenchymal Transition Of Bgc-823 Cells Through Nf-Kappa B/Snail Signaling Pathway

Identification of CK2α’ selective inhibitors by the screening of an allosteric-kinase-inhibitor-like compound library

Exploring the prominent performance of CX-4945 derivatives as protein kinase CK2 inhibitors by a combined computational study.